You are here: Industry Insights > Remdesivir

News List

Saptagir Labs signs manufacturing deal with Jubilant Generics for remdesivir expresspharma
September 15, 2020
The drug will be produced at its sterile drug product manufacturing plant in Hyderabad which is WHO GMP certified.
FDA expands emergency use authorisation for remdesivir to treat all COVID-19 patients europeanpharmaceuticalreview
September 02, 2020
The FDA has expanded the Emergency Use Authorisation for Veklury (remdesivir) to treat all hospitalised patients with COVID-19.
FDA Broadens EUA for Remdesivir for COVID-19 americanpharmaceuticalreview
September 01, 2020
The U.S. Food and Drug Administration (FDA) has broadened the scope of the existing emergency use authorization (EUA) for the drug Veklury (remdesivir) to include treatment of all hospitalized adult and pediatric patients with suspected or ...
FDA grants EUA for Gilead’s remdesivir to treat Covid-19 pharmaceutical-technology
September 01, 2020
The US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) for Gilead Sciences’ Veklury (remdesivir) to treat all hospitalised patients with Covid-19.
Remdesivir has only marginal benefit for moderate COVID-19 patients expresspharma
August 24, 2020
The 600-patient analysis found that moderately-ill patients treated with Remdesivir for up to five days had significantly higher odds of improvement compared to a 10-days course.
Zydus Cadila launches remdesivir at Rs 2800 per 100 mg vial expresspharma
August 14, 2020
To be sold under brand name Remdac, the API for the drug has been developed and manufactured at the company’s API manufacturing facilities in Gujarat.
Remdesivir shortage is India is easing: Cipla expresspharma
August 13, 2020
The company has informed that it has started producing remdesivir at a plant in Goa in western India to ramp up production.
Gilead seeks full approval for remdesivir from US FDA for COVID-19 treatment expresspharma
August 12, 2020
To boost the drug’s availability globally, Gilead has signed multiple manufacturing and supply deals, including with Pfizer and Britain’s Hikma Pharmaceuticals.
Pfizer signs multi-year deal to manufacture Gilead’s remdesivir pharmaceutical-technology
August 11, 2020
Pfizer has entered into a multi-year agreement to manufacture and supply Gilead Science’s experimental antiviral drug remdesivir, for the treatment of Covid-19 patients.
Everest Organics develops remdesivir API expresspharma
August 11, 2020
The company has plans for the development of more products in the anti-viral segments in the future.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page